
Industry concerns about Steve Jobs' health have not gone away more than a month after the Apple CEO appeared dramatically thinner at the firm's annual developers' conference, fighting what insiders at the time were calling a "bug."
Apple is due to report earnings today, but many investors and analysts remain as interested in news of the condition of the tech titan - who is a survivor of pancreatic cancer - as they are in the numbers themselves.
"Apple's hedge fund investors are very worried," said a Wall Street source who has spoken with some of the company's stakeholders.
Apple is due to report earnings today, but many investors and analysts remain as interested in news of the condition of the tech titan - who is a survivor of pancreatic cancer - as they are in the numbers themselves.
"Apple's hedge fund investors are very worried," said a Wall Street source who has spoken with some of the company's stakeholders.

No comments:
Post a Comment